Health and Fitness Health and Fitness
Tue, February 21, 2012
[ Tue, Feb 21st 2012 ] - Market Wire
Magellan Health Services to Present at Upcoming Investor Conferences
[ Tue, Feb 21st 2012 ] - Market Wire
Black Smoker Corporate Update
[ Tue, Feb 21st 2012 ] - Market Wire
DHR International Completes Search for Sparton Corporation
[ Tue, Feb 21st 2012 ] - Market Wire
Faruqi & Faruqi, LLP Announces Investigation of Prestige Brands Holdings, Inc.
[ Tue, Feb 21st 2012 ] - Market Wire
Ligand to Present at the Citi Global Health Care Conference on February 28th
[ Tue, Feb 21st 2012 ] - Market Wire
Mylan Secures an Additional $300 Million of Committed Financing
[ Tue, Feb 21st 2012 ] - Market Wire
Natus to Present at Citi 2012 Global Health Care Conference
[ Tue, Feb 21st 2012 ] - Market Wire
A Phase 3 Study to Assess Repeat Treatment Effica .. 0MG TID in Subjects with Irritable Bowel Syndrome
[ Tue, Feb 21st 2012 ] - Market Wire
Hospira Works With FDA to Help Avert Methotrexate .. One Month's Supply of New Product Immediately and
[ Tue, Feb 21st 2012 ] - Market Wire
Community Health Systems, Inc. to Participate in Two Investor Conferences in February
[ Tue, Feb 21st 2012 ] - Market Wire
American Oriental Bioengineering Inc. Announces Plans for Reverse Stock Split of its Common Stock
[ Tue, Feb 21st 2012 ] - Market Wire
Quest Diagnostics Offers Industry-First 30-Day Am .. R Implementation Guarantee for Hospitals and IDNs
[ Tue, Feb 21st 2012 ] - Market Wire
MIT Receives First ARRONAX Shipment, Launching Strontium-82 Validation Project
[ Tue, Feb 21st 2012 ] - Market Wire
BRILINTA (ticagrelor) Added to American College o .. tions on Antithrombotic Therapy and Prevention of
[ Tue, Feb 21st 2012 ] - Market Wire
IGSM Group INC. Lays the Foundation for the Master Plan of a Holding Company
[ Tue, Feb 21st 2012 ] - Market Wire
ImmunoCellular, Willis Group Holdings, Encana, Exxon Mobil and Cenovus Energy
[ Tue, Feb 21st 2012 ] - Market Wire
Avanir Pharmaceuticals to Participate in Citi 2012 Global Health Care Conference
[ Tue, Feb 21st 2012 ] - Market Wire
Gilead Sciences, Chesapeake Energy, Wells Fargo, Applied Materials, and Pfizer
[ Tue, Feb 21st 2012 ] - Market Wire
Telik Announces Expansion of Phase 2 Trial of Telcyta in Hematologic Malignancies
[ Tue, Feb 21st 2012 ] - Market Wire
Peter A. Marmerstein Appointed President of West Florida Division
[ Tue, Feb 21st 2012 ] - Market Wire
Boston Scientific, Alcoa, Alcatel-Lucent, Atmel, and Delta Air Lines
[ Tue, Feb 21st 2012 ] - Market Wire
Enzo Biochem Receives Approval for Novel Blood Based Test for Colorectal Cancer Risk
[ Tue, Feb 21st 2012 ] - Market Wire
Dehaier Medical Retains The Equity Group to Provide Investor Relations Services
[ Tue, Feb 21st 2012 ] - Market Wire
Genomma Lab Internacional Announces Non-binding P .. tige Brands Holdings for $16.60 Per Share in Cash
[ Tue, Feb 21st 2012 ] - Market Wire
Paladin Announces Strategic Partnership with Lith .. erging of South African Pharmaceutical Businesses
[ Tue, Feb 21st 2012 ] - Market Wire
EnteroMedics to Participate in 4th Annual Lazard Capital Markets Medical Technology Conference
[ Tue, Feb 21st 2012 ] - Market Wire
Theratechnologies Announces a Supply, Distributio .. ng Agreement With Actelion Pharmaceuticals Canada
[ Tue, Feb 21st 2012 ] - Market Wire
AcelRx Pharmaceuticals to Present at Two Near-Term Health Care Conferences
[ Tue, Feb 21st 2012 ] - Market Wire
Cytokinetics Announces Initiation of Phase I Clin .. tions of Omecamtiv Mecarbil in Healthy Volunteers
[ Tue, Feb 21st 2012 ] - Market Wire
Horizon Pharma to Present at the Cowen and Company Health Care Conference

Horizon Pharma to Present at the Cowen and Company Health Care Conference


Published on 2012-02-21 04:36:05 - Market Wire
  Print publication without navigation


February 21, 2012 07:30 ET

Horizon Pharma to Present at the Cowen and Company Health Care Conference

DEERFIELD, IL--(Marketwire - Feb 21, 2012) - Horizon Pharma, Inc. (NASDAQ: [ HZNP ]) today announced that Timothy P. Walbert, chairman, president and chief executive officer, will present at the Cowen and Company 32nd Annual Health Care Conference on Monday, March 5th at 4:50p.m. Eastern Time in Boston, MA. Mr. Walbert will provide an overview of the Company and its corporate activities.

The presentation will be webcast live and may be accessed by visiting Horizon's website at [ http://ir.horizon-pharma.com ]. A replay of the webcast will be available for 10 business days.

About Horizon Pharma
Horizon Pharma, Inc. is a biopharmaceutical company that is developing and commercializing innovative medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. For more information, please visit [ www.horizonpharma.com ].


Contributing Sources